Donepezil and Memantine for Moderate-to-Severe Alzheimer's DiseaseRobert Howard, Patrick Phillips, Rob Jones et al.|New England Journal of Medicine|2012Cited by 774
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Richard Gray, Patrick Phillips et al.|International Journal of Geriatric Psychiatry|2010Cited by 177
Increased Prevalence of Insomnia and Changes in Hypnotics Use in England over 15 Years: Analysis of the 1993, 2000, and 2007 National Psychiatric Morbidity SurveysMaria Calem, Robert Stewart, Jatinder Bisla et al.|SLEEP|2012Cited by 172
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Patrick Phillips, Rupert McShane et al.|The Lancet Neurology|2015Cited by 164
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)Martín Knapp, Robert Howard, Derek King et al.|International Journal of Geriatric Psychiatry|2016Cited by 63